Tag

Alzheimers Disease

Dried blood spot testing for Alzheimer's biomarker analysis

Editorial ArticleClinical Diagnostics

Dried blood spot testing is revolutionizing Alzheimer’s monitoring

Discover how advances in dried blood spot testing are advancing biomarker analysis and sample collection

17 Jun 2025

Product NewsClinical Diagnostics

Revvity’s EUROIMMUN unveils new fully automated instrument for specialty testing

23 May 2025

Industry NewsLife Sciences

Aptamer Group and Neuro-Bio advance Alzheimer’s test and agree royalties

8 May 2025

Product NewsClinical Diagnostics

Leqembi (lecanemab) is the first medicine that slows progression of early Alzheimer's disease to be authorized in the EU

29 Apr 2025

Webinars

Bringing the proteome into focus with single-molecule proteome and proteoform analysis

Jun 30, 2025

Breaking Barriers in Disease Diagnosis: Expanding Access to Early Detection with Advanced Immunoassays

Available on-demand

Editorial Articles

Dried blood spot testing for Alzheimer's biomarker analysis

Dried blood spot testing is revolutionizing Alzheimer’s monitoring

17 Jun 2025

Alzheimers disease brain imaging

Challenges to Alzheimer's disease diagnosis and the emerging treatment landscape

10 Nov 2024

Industry News

Aptamer Group and Neuro-Bio advance Alzheimer’s test and agree royalties

8 May 2025

APOE genotyping recommended prior to Alzheimer’s therapy

26 Feb 2025

Spear Bio's pTau 217 blood test earns FDA breakthrough designation

14 Jan 2025

Roche presents new data highlighting advances in Alzheimer’s diagnostics

5 Nov 2024

Latest Videos

The future of Alzheimer's biomarker testing

The future of Alzheimer's biomarker testing

27 May 2025

Andy Hay, Sysmex America Ltd. and Sonia Nicholas, SelectScience, interview for CLINICAL24

CLINICAL24: Challenges, collaborations, and innovations in hematology

21 Oct 2024

Kevin O'Reilly, President, Beckman Coulter Diagnostics

Celebrating a new era of diagnostic innovation

29 Aug 2024